You are here
- Home
- Drug Products
- All Drug Products
Investigating safety, tolerability and pk when giving single and fractionated doses of AZD3241 to healthy volunteers
- Disease
- Parkinson's disease
- Drug Name
- AZD3241
- Generic Name
- AZD3241
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jul 29, 2008
- Study Name
- D0490C00012
- Study Id
- D0490C00012
- ClinicalTrials.gov ID
- NCT00729443
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
